| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/12/2002 | US20020127642 Porcine leptin protein, antisense and antibody |
| 09/12/2002 | US20020127640 Pancreas-derived plasminogen activator inhibitor |
| 09/12/2002 | US20020127639 Nucleotide sequences coding protein for use in the treatment of diabetes, hyperlipidemia and eating disorders |
| 09/12/2002 | US20020127638 Human metabotropic glutamate receptor 7 subtypes |
| 09/12/2002 | US20020127637 Nucleotide sequences coding protein for use in the diagnosis and treatment of cell proliferation defects |
| 09/12/2002 | US20020127636 Ankyrin repeat domain 2 protein variant |
| 09/12/2002 | US20020127624 INGAP displacement assays |
| 09/12/2002 | US20020127620 Intraflagellar transport |
| 09/12/2002 | US20020127618 Diagnosing crytosporidium infection of mammals; obtain feces sample from mammal, incubate with binding agent which binds to protein disulfide isomerase, detect bound isomerase, bound isomerase indicates cryptosporidium infection |
| 09/12/2002 | US20020127615 Protein for use in the treatment of autoimmune, skin, kidney, liver and blood disorders |
| 09/12/2002 | US20020127613 Isolated nucleic acid molecules which encode GAGE genes and uses thereof |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127602 Troponin I polypeptide fragments and uses thereof |
| 09/12/2002 | US20020127601 Detecting modulators of g-protein coupled receptor activity; obtain cell containing g-protein coupled receptor pathway, incubate with modulator, determine quantative and qualitative effect of modulator on receptor |
| 09/12/2002 | US20020127600 Uncoupling protein for use in the treatment of body weight defects |
| 09/12/2002 | US20020127599 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof |
| 09/12/2002 | US20020127596 murF2 |
| 09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
| 09/12/2002 | US20020127594 Nucleotide sequences coding polypeptide for use in the treating and diagnosing cell proliferative defects |
| 09/12/2002 | US20020127584 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/12/2002 | US20020127583 Detecting prion protein in sample; obtain tissue sample, incubate with binding protein, detect bound complex |
| 09/12/2002 | US20020127582 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 09/12/2002 | US20020127579 Breast carcinoma-associated gene |
| 09/12/2002 | US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders |
| 09/12/2002 | US20020127568 Nucleotide sequences coding protein for use in the treatment of cellular proliferation, differentiation, cardiovascular, liver, pain, metabolic, brain, blood disorders, hematopoietic and platelet disorders |
| 09/12/2002 | US20020127567 Nucleotide sequence coding transport protein for use in the diagnosis and treatment of liver disorders |
| 09/12/2002 | US20020127564 Monitoring modulators of phenotypic expression in mammalian cells; obtain cell, transform, screen transformed cells for preferential phenotype |
| 09/12/2002 | US20020127559 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions |
| 09/12/2002 | US20020127556 DNA encoding human Cid2 |
| 09/12/2002 | US20020127553 Apoptin-associating protein |
| 09/12/2002 | US20020127548 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 09/12/2002 | US20020127545 Assessment of human papilloma virus-related disease |
| 09/12/2002 | US20020127544 Kit for the detection of modulator which prevent viral diseases |
| 09/12/2002 | US20020127538 Modifications of the VEGF receptor-2 protein and methods of use |
| 09/12/2002 | US20020127247 Modified clostridial neurotoxins with altered biological persistence |
| 09/12/2002 | US20020127245 Canine coronavirus S gene and uses therefor |
| 09/12/2002 | US20020127244 Fractionating a mixture of polyethylene glycol(PEG)-protein adducts comprising partitioning the PEG/protein adducts in a PEG-containing aqueous biphasic system |
| 09/12/2002 | US20020127241 For detection, diagnosis, prevention and treatment of malaria |
| 09/12/2002 | US20020127240 Leptospiral rare outer membrane proteins |
| 09/12/2002 | US20020127239 LipL32 polypeptide is useful for inducing an immune response to a pathogenic spirochete in a patient |
| 09/12/2002 | US20020127238 Utilizing a modified HIV-1 envelope protein or fragment or DNA encoding a modified HIV-1 envelope protein or fragment, wherein modified protein having a HIV-1 envelope protein V2 region deletion |
| 09/12/2002 | US20020127237 Contacting sample with preferntial nucleic acid molecule in which the nucleic acid will selectively hydbridize to a prostate specific nucleic acid, detecting hybridization of nucleic acid molecule to prostate specific nucleic acid |
| 09/12/2002 | US20020127236 Contacting the sample containing an antibody specific for isolated and purified antigenically-active blood group antigen protein or peptide to allow the formation of an immune complex; and detecting the immune complex |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127232 Activating alpha 2-macroglobulin by incubation with a nucleophilic compound to form nucleophile-activated alpha 2-macroglobulin, removing excess of nucleophilic compound, incubating activated alpha-2 macroglobulin with biomolecule |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127226 Tyrosine phosphatase receptor protein- tenascin ligand complex |
| 09/12/2002 | US20020127225 Nucleic acid and amino acid sequences of an annexin binding protein useful in diagnosis, prevention, treatment of cancer, immune disorder and neurological disorders |
| 09/12/2002 | US20020127222 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127219 A polypeptide selected from lysosomal enzymes and lysosomal enzyme activators, consist of at least one introduced glycosylation site as compared to a corresponding parent enzyme or activator |
| 09/12/2002 | US20020127214 RAC-protein kinase as therapeutic agent or in diagnostics |
| 09/12/2002 | US20020127209 Tripeptide of intracellular tyrosine-based activation motifs (ITAM) mediates trafficking of targets phagocytosed via Fc gamma RIIA to the lysosomal compartment |
| 09/12/2002 | US20020127205 Immunoregulatory molecule expressed by the cell(s) are capable of inhibiting T cell activation and/or natural killer cell-mediated immune response against the cell upon transplantation into a recipient subject |
| 09/12/2002 | US20020127204 Improvements in or relating to protection against intracellular infection |
| 09/12/2002 | US20020127201 Contacting T cell with agent which binds to cytokine receptor gamma chain and stimulates an intracellular signal in T cell resulting in T cell proliferation, with proviso that agent does not consist of natural interleukin-2 |
| 09/12/2002 | US20020127200 Canine interleukin-5 proteins, canine interleukin-5 nucleic acid molecules |
| 09/12/2002 | US20020127199 Novel nucleic acids and polypeptides |
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | DE10109466A1 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 09/12/2002 | DE10059595A1 Proteine und den Proteinen zugrundeliegende DNA-Sequenzen mit Funktion bei Entzündungsereignissen Proteins and the proteins underlying DNA sequences function in inflammatory events |
| 09/12/2002 | CA2743731A1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | CA2710031A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | CA2709871A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2441476A1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | CA2440513A1 Nucleic acids for transforming fish cells and methods for their use |
| 09/12/2002 | CA2440358A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 09/12/2002 | CA2440257A1 Novel nucleic acids and polypeptides |
| 09/12/2002 | CA2440235A1 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 09/12/2002 | CA2440092A1 Protein c variants |
| 09/12/2002 | CA2439990A1 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/12/2002 | CA2439986A1 Cell visual characteristic-modifying sequences |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439933A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | CA2439929A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | CA2439926A1 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | CA2439843A1 Compositions and methods for increasing amino acid absorption in mammals |
| 09/12/2002 | CA2439682A1 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | CA2439681A1 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439625A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | CA2439620A1 Viral reporter particles |
| 09/12/2002 | CA2439607A1 The guinea pig proteinase-activated receptor 4 and its activating peptide |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439584A1 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
| 09/12/2002 | CA2439579A1 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | CA2439456A1 Novel abcg4 transporter and uses thereof |
| 09/12/2002 | CA2439454A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |